Amedica Prices $11 Million Public Offering

Amedica (AMDA) priced an underwritten public offering for gross proceeds of US $11MM, prior to various deductions (e.g., underwriting discounts, commissions and offering expenses). Closing is expected to occur by 7/8/16.

Net proceeds will support R&D/clinical trials, commercialization of product candidates, sales/marketing distribution of...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us